A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea
Recruiting
Observational Study
Complicated Intra-abdominal Infection
Complicated Urinary Tract Infection
Hospital-acquired Pneumonia
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 3 Months and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- Pfizer · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to learn about the safety and effectiveness of Zavicefta once released into the markets in Korea. This study is to learn about Zavicefta in patients with difficult types of infections in the abdomen, urinary tract and pneumonia which could have come from hospitalizations. This study was required by the Ministry of Food and Drug Safety (MFDS) of Korea's regulations.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
1. Adults and paediatric patients aged 3 months and older, who have been administered at least one dose of Zavicefta for the treatment of one of the indications as follows:
* Complicated intra-abdominal infection (cIAI)
* Complicated urinary tract infection (cUTI), including pyelonephritis
…
Contacts